Talactoferrin alfa (Agennix)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameTalactoferrin alfa (Agennix)
Drug Alias NamerhLFLactoferrin - AgennixApolactoferrinTalactoferrinTLF - Agennix
ClassificationBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionImmunomodulatorsMacrophages stimulants
TargetsNot applicable
Therapy Area/IndicationsDiabetic FootAsthmaMucositis +[9] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesAgennix
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAgennix
Active IndicationsN/A
Inactive IndicationsDiabetic FootAsthmaMucositis +[9] 

Other Information

ATC CodeN/A
Related LinksDrugBankKEGG